Clinical Trial Update: Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 double-blind, placebo-controlled trial evaluated losartan for Grade II–III hamstring strains but was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hamstring Injury

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: James J. Irrgang | Conditions: Hamstring Injury | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-05-02